Next Article in Journal
Evaluation of the Putative Duplicity Effect of Novel Nutraceuticals Using Physico-Chemical and Biological In Vitro Models
Previous Article in Journal
Effects of Peroxyl Radicals on the Structural Characteristics and Fatty Acid Composition of High-Density Lipoprotein from Duck Egg Yolk
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Foods
Volume 11
Issue 11
10.3390/foods11111635
foods-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Association of Seaweed Consumption with Metabolic Syndrome and Its Components: Findings from the Korean Genome and Epidemiology Study

by
Haeun Park
1,
Kyung Won Lee
2,* and
Dayeon Shin
1,*
1
Department of Food and Nutrition, Inha University, Incheon 22212, Korea
2
Department of Home Economics Education, Korea National University of Education, Cheongju 28173, Korea
*
Authors to whom correspondence should be addressed.
Foods 2022, 11(11), 1635; https://doi.org/10.3390/foods11111635
Submission received: 26 April 2022 / Revised: 23 May 2022 / Accepted: 26 May 2022 / Published: 1 June 2022
(This article belongs to the Section Food Nutrition)
Browse Figure
Versions Notes

Abstract

:
This study aimed to investigate the association between seaweed consumption and the odds of developing metabolic syndrome in middle-aged and elderly Koreans. The study included 5777 adults aged 40–69 years from 2001 to 2002 in the Ansan and Ansung cohorts of the Korean Genome and Epidemiology Study. Data on the consumption of seaweed, including laver and kelp/sea mustard, were obtained using a semiquantitative food frequency questionnaire. Multivariable logistic regression models were used to assess the association between seaweed consumption and the odds of developing metabolic syndrome and its components. Women in the highest tertile of laver consumption had lower odds of developing metabolic syndrome than those in the lowest tertile (adjusted odds ratio [AOR]: 0.70; 95% confidence interval [CI]: 0.54–0.92). Both men and women in the highest tertile of laver consumption had lower odds of abdominal obesity than those in the lowest tertile (AOR: 0.64, 95% CI: 0.42–0.98 for men; AOR: 0.53, 95% CI: 0.39–0.72 for women). These findings suggest that laver consumption is inversely associated with the odds of developing metabolic syndrome and abdominal obesity in Korean adults.

1. Introduction

Metabolic syndrome is characterized by three or more of the following conditions: abdominal obesity, hypertriglyceridemia, low high-density lipoprotein (HDL) cholesterol levels, hypertension, and hyperglycemia [1,2]. As the prevalence of obesity continues to increase, the prevalence of metabolic syndrome also increases [3,4,5]. In Korea, the overall prevalence of metabolic syndrome has increased by approximately 3% over 10 years, from 21.6% in 2007 to 24.5% in 2017 (men, 28.1%; women, 18.7%) [6]. As metabolic syndrome may also increase the risk of type 2 diabetes and cardiovascular diseases, its management and treatment are important [7,8]. Accordingly, investigations are needed to identify modifiable risk factors for metabolic syndrome that can help prevent the disease.
Metabolic syndrome is caused by poor lifestyle management, such as an unhealthy diet, smoking, excessive alcohol consumption, and lack of physical activity [9,10]. Among middle-aged men, those who exercised <5 times a week were approximately 1.5 times more likely to develop hypertriglyceridemia, have low HDL cholesterol levels, and develop abdominal obesity than those who exercised at least five times a week [11]. In addition, current smoking status and alcohol consumption are significantly associated with individual parameters of metabolic syndrome, including obesity, triglyceride levels, insulin levels, and the score for the homeostatic model assessment of insulin resistance [12,13]. It has been reported that a healthy diet is the most important lifestyle factor. Previous studies have reported that those who practice healthy dietary habits have significantly lower prevalence rates of abdominal obesity and metabolic syndrome than those who do not [14]. A healthy diet includes an adequate intake of fat, a low intake of sodium, and sufficient consumption of fruits and vegetables, including seaweed [15]. Seaweed is widely consumed by individuals in East Asian countries—especially in Korea, China, and Japan [16,17]. According to an analysis of the recent Korea National Health and Nutrition Survey, the daily seaweed consumption per person was 3.5 g (3.7 g for men and 3.2 g for women) [18]. Laver (Porphyra sp.; red algae), sea mustard (Undaria pinnatifida; brown algae), kelp (Laminaria sp.; brown algae), Enteromorpha (green algae), Capsosiphon fulvescens (green algae), and Hizikia fusiforme (brown algae) have also been reported to be consumed by these populations [19]. The average daily intake differed depending on the type of seaweed: 1.04 g of laver, 0.94 g of kelp, 0.77 g of sea mustard, 0.33 g of C. fulvescens, 0.30 g of Enteromorpha, and 0.12 g of H. fusiforme [20]. Seaweed contains compounds such as polysaccharides, peptides, and carotenoids, which play a role in controlling obesity and metabolic syndrome [21,22]. Polysaccharides in seaweed have been identified as prebiotic fibers that can be fermented to produce short-chain fatty acids, which help prevent metabolic syndrome by changing the composition of the gut bacteriome and increasing the production of short-chain carboxylic acids [23,24,25]. Extracts of Porphyra dentata play a role in preventing obesity by exhibiting dual-generative inhibitory properties in 3T3-L1 cells [26]. In addition, the concentration of P. dentata extract was significantly associated with the suppression of obesity-induced gene expression in 3T3-L1 cells [26]. Functional peptides—another component of seaweed—are known to inhibit the activity of angiotensin-converting enzymes, which lower blood glucose levels and blood pressure [27,28]. Previous experiments using rat models have demonstrated the beneficial effects of seaweed extracts, such as fucoidans and polysaccharides, on metabolic syndrome and its components. Seaweed extracts reportedly inhibit lipid accumulation in the blood and exert an anti-obesity effect by reducing the weight and mass of adipose tissues. In addition, seaweed and its polysaccharides exert anti-hyperlipidemic and anti-hypertensive effects, which are potentially useful for preventing or managing cardiovascular diseases [29]. However, a previous animal study reported that levels of HDL cholesterol and triglycerides increased, but with no change in LDL cholesterol levels, when rats were fed a diet containing various types of seaweed, such as Ulva spp. and Hypnea charoides [30].
However, little is known about the association between seaweed consumption and metabolic syndrome or its components in Korean adults. Therefore, this study aimed to examine the association between seaweed consumption and metabolic syndrome among middle-aged and elderly adults in Korea using the Korean Genome and Epidemiology Study (KoGES).

2. Materials and Methods

2.1. Study Participants

This study used data from the Ansan and Ansung cohort studies of KoGES which was designed to identify the risk factors for chronic diseases in Koreans and collects epidemiological data on health and lifestyles [31]. The Ansan and Ansung cohort studies began with men and women, aged 40–69 years, living in Ansan (an industrialized community) and Ansung (a rural area) in 2001, respectively. The KoGES recruited survey participants from 2001 to conduct repeated follow-up investigations until 2019, to collect information on metabolic factors, food frequency questionnaires (FFQs), and other variable data.
For this study, of the total 10,030 potential participants, the following were excluded: those without laver or kelp/sea mustard intake data (n = 334); those with cancer or cardiovascular disease (n = 1403); those without waist circumference, blood pressure, or blood glucose values (n = 94); and those without information on covariates, including alcohol consumption, smoking status, education level, income level, body mass index (BMI), and physical activity (n = 2422). Of the remaining 5777 participants, 2836 (49.1%) were male (Figure 1). The study protocol was reviewed and approved by the Institutional Review Board (IRB) of Inha University on 31 January 2020 (IRB No. 200129–1A).

2.2. Assessment of Metabolic Syndrome and Its Components

The dependent variables in this study were the presence of metabolic syndrome and the presence of its individual components. Participants were confirmed to have metabolic syndrome if they had more than three of the following: abdominal obesity, elevated triglycerides, elevated fasting glucose, elevated blood pressure, and low HDL cholesterol. Waist circumference was measured using a tape placed horizontally around the middle area between the rib and the iliac ridge. The average measurement from a total of three measurements was calculated. Men with a waist circumference ≥ 90 cm and women with a waist circumference ≥ 80 cm were defined as having abdominal obesity [32]. Triglyceride, fasting blood glucose, and HDL cholesterol levels were measured using an ADVIA 1650 Clinical Chemistry Analyzer. Participants were classified as having hypertriglyceridemia if their triglyceride level was ≥ 150 mg/dL [3,33]. Participants were classified as having diabetes if their fasting blood glucose level was ≥ 126 mg/dL, if they were currently being treated for diabetes using hypoglycemic agents or insulin, or if they had a history of receiving treatment for diabetes [34]. Men with an HDL cholesterol level < 40 mg/dL and women with an HDL cholesterol level < 50 mg/dL were classified as having low HDL cholesterol levels [3,33]. Blood pressure was measured at least twice at every visit in a seated position, with the arms positioned at the level of the heart. Elevated blood pressure was defined as systolic blood pressure > 130 mmHg, diastolic blood pressure > 85 mmHg, history of hypertension, blood pressure medication, or current treatment for hypertension.

2.3. Assessment of Seaweed Consumption

Seaweed consumption was assessed by measuring the intakes of laver, kelp/sea mustard, and total seaweed. The total seaweed consumption was determined by combining the average daily intake of laver and kelp/sea mustard, which was determined using a semi-quantitative FFQ. The FFQ displays a list of 106 food items frequently consumed by Koreans and examines their frequency and amount of consumption over the past year. The standard amount of laver per intake was one sheet (large), while that of kelp/sea mustard was one bowl of soup.
The intake frequency was categorized into nine timeframes (i.e., none, almost once a month, 2–3 times a month, 1–2 times a week, 3–4 times a week, 5–6 times a week, once a day, twice a day, and 3 times a day). The portion size of each food item was categorized as small (half the standard portion size), medium (one standard portion size), or large (two standard portion sizes). In this study, the frequency of intake was converted to daily intake. The intake amount was converted into grams. The study participants were classified into three groups based on their average daily intake (g) of seaweed, laver, and kelp/sea mustard.

2.4. Assessment of Other Variables

BMI was calculated by dividing body weight (kg) by the square of height (m). Education level was divided into three categories: elementary/middle school, high school/professional college, and university. Income level was also categorized into three categories: <1 million won, between 1–3 million won, and >3 million won per month. Smoking status and alcohol consumption were classified as none, past, or current. Physical activity levels were evaluated to determine time spent sedentary and the time spent participating in low-, medium-, or high-intensity activities. The average metabolic equivalent of task (MET) value for each activity was calculated by assigning the MET values to each degree of physical activity. Activity time was converted to hours and multiplied by the average MET value. All values were combined to obtain the total number of MET-hours per day.

2.5. Statistical Analyses

General and clinical characteristics and dietary intake of the study participants according to tertiles of seaweed consumption were compared using analysis of variance for continuous variables and chi-squared tests for categorical variables. Multivariable logistic regression analysis was used to calculate the adjusted odds ratios (AORs) for the association between total seaweed, laver, and kelp/sea mustard consumption and metabolic syndrome and its components, after controlling for covariates. The covariates included age; sex; region; alcohol consumption; smoking; education and income level; BMI; physical activity; total energy intake; and protein, fat, carbohydrate, and fiber intake. The p-value for trend was calculated by modeling the median values of seaweed, laver, and kelp/sea mustard intake as continuous variables in each tertile. Statistical significance was set at p-value < 0.05. The IBM SPSS Statistics 26 package (IBM, Armonk, NY, USA) was used for statistical analyses.

3. Results

3.1. General Characteristics According to Total Seaweed Consumption

The general characteristics of the study population according to the tertiles of total seaweed consumption are presented in Table 1. Compared with participants in the lowest tertile of total seaweed consumption, those in the highest tertile were younger with higher education levels, higher incomes and higher BMI, and they resided in urban areas (all p-values < 0.05). Those in the highest total seaweed consumption tertile were less likely to be current smokers, currently consuming alcohol, or physically active (all p-values < 0.05).

3.2. Dietary Intake and Clinical Characteristics According to Total Seaweed Consumption

The dietary intake and characteristics of the metabolic syndrome parameters according to tertiles of total seaweed consumption are shown in Table 2. Total seaweed consumption was significantly associated with dietary intake, with a higher intake of total energy, protein, fat, carbohydrates, and fiber in the highest tertile group (all p-values < 0.001). In addition, individuals in the highest tertile of total seaweed consumption had approximately seven times higher intakes of total seaweed, laver, and kelp/sea mustard than those in the lowest tertile (all p-values < 0.0001). In terms of the components of metabolic syndrome, there was a significant difference only in blood pressure according to the total seaweed consumption. Those in the highest total seaweed consumption tertile exhibited lower systolic (116.7 ± 16.4 vs. 118.4 ± 16.4 mmHg) and diastolic blood pressure (78.0 ± 11.0 vs. 78.8 ± 10.7 mmHg) (all p-values < 0.0001) than those in the lowest tertile group.

3.3. Association between Seaweed Consumption and the Odds of Developing Metabolic Syndrome and Its Components

The associations between total seaweed, laver, and kelp/sea mustard consumption and the prevalence of metabolic syndrome was analyzed (Table 3). Women in the highest tertile exhibited lower odds of developing metabolic syndrome than those in the lowest tertile of laver consumption (AOR = 0.70, 95% confidence interval (CI): 0.54–0.92; p < 0.05). However, total consumption of seaweed and kelp/sea mustard was not significantly associated with metabolic syndrome.
We further examined the odds of individual metabolic syndrome components according to the total consumption of seaweed, laver, and kelp/sea mustard (Table 4). Laver consumption was significantly associated with abdominal obesity in both men and women. Compared with the individuals in the lowest tertile of laver consumption, those in the highest tertile had reduced odds of abdominal obesity (AOR = 0.64, 95% CI: 0.42–0.98 for men; AOR = 0.53, 95% CI: 0.39–0.72 for women). However, no significant association was observed between total seaweed and kelp/sea mustard consumption and the individual components of metabolic syndrome.

4. Discussion

In the present study, women with higher laver consumption had lower odds of metabolic syndrome. Furthermore, high laver intake was associated with lower odds of abdominal obesity in both men and women. Consistent with our findings, waist circumference in Koreans aged 19–50 years was significantly reduced after 12 weeks of consumption of Gelidium elegans (red algae) [35]. Our findings also indicate that there is no association between the total seaweed intake and metabolic syndrome. However, inconsistent findings have been reported regarding the association between seaweed intake and metabolic syndrome. The consumption of 6 g/day of seaweed may be associated with improved parameters of metabolic syndrome, decreasing waist circumference and blood pressure in a non-seaweed-consuming Andean population [36]. Furthermore, iodine and seaweed intake results in low blood glucose, blood pressure, and triglyceride levels in post-menopausal Korean women [25]. Meanwhile, Korean men aged ≥30 years with increased seaweed intake, such as laver, had an increased risk of metabolic syndrome [37]. These inconsistent findings regarding seaweed intake and metabolic syndrome may be partially due to age differences in the target study populations. Furthermore, the rates of current smokers and those consuming alcohol were approximately double than those of our study participants. These differences may have influenced the contrasting findings.
According to a Japanese study, frequent consumption of seaweed is likely to reduce serum triglyceride levels in participants with abnormally high levels [38]. This may be partially due to the fact that seaweed-soluble dietary fibers are highly viscous and, thus, hinder the absorption of triglycerides [39]. In another study, rats that consumed seaweed after being stressed showed higher triglyceride levels than control rats [40]. These findings suggest that seaweed consumption does not improve serum triglyceride levels. In line with this, we found that seaweed consumption was not significantly associated with hypertriglyceridemia. In addition, we did not find any significant association between seaweed consumption and hyperglycemia. Contrary to our findings, previous studies have shown that low-molecular-weight polysaccharides obtained from laver via hydrogen peroxide decomposition have excellent hypoglycemic and α-amylase-inhibitory activities in rats [41]. Koreans aged 40–69 years who ate seaweed—especially kelp and sea mustard—had a reduced risk of diabetes [42]. Seaweed consumption reduces the risk of hyperglycemia, because protein hydrolysates and peptides derived from seaweed may lower blood-glucose levels [28].
Seaweed polysaccharides have antihypertensive effects in rats [43]. In a study on young children in Japan, the consumption of laver showed a diastolic-blood-pressure-lowering effect in boys [44]. Although several studies have reported significant relationship between blood pressure and seaweed consumption, no relationship was found between hypertension and seaweed consumption in the present study. The difference in the results of this study reflects the variations between the environments of Japan and Korea, which differ in terms of climate, sea environment, and lifestyle, including the consumption of specific foods. In addition, seaweed peptides, which are effective in preventing hyperglycemia, have been reported to exert antihypertensive effects [28].
In the present study, seaweed consumption was not significantly associated with low HDL cholesterol levels. In line with our findings, several studies have reported no association between seaweed consumption and HDL cholesterol levels [45,46]. In rats fed kelp-supplemented cabbage kimchi, the concentration of triglycerides decreased significantly. However, no significant changes were observed in HDL cholesterol levels [45]. A previous study showed that Ecklonia cava—a brown seaweed—improved LDL/HDL cholesterol ratios in diabetic rodents [47]. However, another study found that HDL cholesterol levels increased when rodents consumed a seaweed porphyran drink after consuming a high-cholesterol diet [48]. This difference in the results may be due to an inconsistent relationship between seaweed consumption and HDL-C, and these investigations are usually conducted in vivo, often in rats.
This study has several strengths. First, this is the first population-based study to investigate the association between seaweed, laver, kelp/sea mustard, and metabolic syndrome and its components. Second, we evaluated the independent association between seaweed consumption and metabolic syndrome by correcting for variables that could affect the results, such as age, alcohol consumption, smoking status, physical activity, and dietary intake of other foods.
The study also had some limitations. The mechanism by which seaweed consumption affects metabolic syndrome and its components has not yet been assessed. Furthermore, the composition of seaweed varies greatly depending on the harvesting region and growing conditions [49]. Because the growth conditions of seaweed differ from region to region, the present study did not demonstrate significant associations between seaweed consumption and metabolic syndrome and its components, except for abdominal obesity. Additionally, the causal relationship between seaweed consumption and metabolic syndrome could not be established, owing to the cross-sectional design of the present study.

5. Conclusions

Laver consumption was associated with lower odds of metabolic syndrome and abdominal obesity among middle-aged and elderly Korean adults. However, no association was found between total seaweed intake including laver and kelp/sea mustard—and metabolic syndrome. Our findings suggest that laver consumption is inversely associated with metabolic syndrome and abdominal obesity. Further studies are warranted to investigate the causal relationship between total seaweed, laver, and kelp/sea mustard intake and the risk of developing metabolic syndrome.

Author Contributions

Conceptualization, H.P. and D.S.; Methodology, H.P. and D.S.; Investigation, H.P., K.W.L. and D.S.; Data Curation, H.P. and D.S.; Writing—Original Draft Preparation, H.P., K.W.L. and D.S.; Writing—Review and Editing, H.P., K.W.L. and D.S.; Supervision, D.S.; Funding acquisition, D.S. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (No. 2020R1G1A1004940). The funders had no role in the study design, data collection and analysis, decision to publish, or manuscript preparation.

Institutional Review Board Statement

The study protocol was reviewed and approved by the Institutional Review Board (IRB) of Inha University on 31 January 2020 (IRB No. 200129–1A).

Informed Consent Statement

The KoGES study was reviewed and approved by the institutional review board of the Korea Centers for Disease Control and Prevention. All participants voluntarily enrolled in the study and provided written informed consent. All study methods and protocols were conducted in accordance with the relevant institutional guidelines and regulations.

Data Availability Statement

The data underlying the results of our study are not publicly available because of the data policy of KoGES. Data are available from the Division of Genetic Epidemiology and Health Index, NIH, Korea Centers for Disease Control and Prevention, for researchers who meet the criteria for access to confidential data.

Acknowledgments

This study was conducted with biosources from the National Biobank of Korea, Centers for Disease Control and Prevention, Republic of Korea (KBN-2020-016).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Ghodsi, S.; Meysamie, A.; Abbasi, M.; Ghalehtaki, R.; Esteghamati, A.; Malekzadeh, M.M.; Asgari, F.; Gouya, M.M. Non–high-density lipoprotein fractions are strongly associated with the presence of metabolic syndrome independent of obesity and diabetes: A population-based study among Iranian adults. Diabetes Metab. J. 2017, 16, 25. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Kim, Y.K. The impact of metabolic syndrome and its components on pulse wave velocity. Korean J. Med. 2005, 68, 140–148. [Google Scholar] [CrossRef]
  3. Klempfner, R.; Erez, A.; Sagit, B.-Z.; Goldenberg, I.; Fisman, E.; Kopel, E.; Shlomo, N.; Israel, A.; Tenenbaum, A. Elevated triglyceride level is independently associated with increased all-cause mortality in patients with established coronary heart disease: Twenty-two–year follow-up of the bezafibrate infarction prevention study and registry. Circ. Cardiovasc. Qual. Outcomes 2016, 9, 100–108. [Google Scholar] [CrossRef] [PubMed]
  4. Lim, J.W.; Kim, S.; Ke, S.S.; Cho, B.l. The prevalence of obesity, abdominal obesity and metabolic syndrome among elderly in general population. Korean J. Fam. Med. 2011, 32, 128–134. [Google Scholar] [CrossRef]
  5. Park, H.S.; Park, C.Y.; Oh, S.W.; Yoo, H.J. Prevalence of obesity and metabolic syndrome in Korean adults. Obes. Rev. 2008, 9, 104–107. [Google Scholar] [CrossRef]
  6. Kim, M.H.; Lee, S.H.; Shin, K.S.; Son, D.Y.; Kim, S.H.; Joe, H.; Yoo, B.W.; Hong, S.H.; Cho, C.Y.; Shin, H.S.; et al. The change of metabolic syndrome prevalence and its risk factors in Korean adults for decade: Korea National Health and Nutrition Examination Survey for 2008–2017. Korean J. Fam. Med. 2020, 10, 44–52. [Google Scholar] [CrossRef]
  7. Biadgo, B.; Melak, T.; Ambachew, S.; Baynes, H.W.; Limenih, M.A.; Jaleta, K.N.; Tachebele, B.; Melku, M.; Abebe, M. The prevalence of metabolic syndrome and its components among type 2 diabetes mellitus patients at a tertiary hospital, northwest Ethiopia. Ethiop. J. Health Sci. 2018, 28, 645–654. [Google Scholar] [CrossRef]
  8. Eckel, R.H.; Grundy, S.M.; Zimmet, P.Z. The metabolic syndrome. Lancet 2005, 365, 1415–1428. [Google Scholar] [CrossRef]
  9. Zhu, S.; St-Onge, M.-P.; Heshka, S.; Heymsfield, S.B. Lifestyle behaviors associated with lower risk of having the metabolic syndrome. Metabolism 2004, 53, 1503–1511. [Google Scholar] [CrossRef]
  10. Maki, K.C. Dietary factors in the prevention of diabetes mellitus and coronary artery disease associated with the metabolic syndrome. Am. J. Card. 2004, 93, 12–17. [Google Scholar] [CrossRef]
  11. Jung, C.H.; Park, J.S.; Lee, W.Y.; Kim, S.W. Effects of smoking, alcohol, exercise, level of education, and family history on the metabolic syndrome in Korean adults. Korean J. Med. 2002, 63, 649–659. [Google Scholar]
  12. Kang, H.S.; Hong, H.R. The effects of body mass index, cardio/respiratory fitness, and smoking on the clustering of the metabolic syndrome risk factors in college male student. J. Leis. Res. 2011, 45, 709–720. [Google Scholar]
  13. Nam, S.M.; Yu, H.Y.; Lee, M.Y.; Koh, J.H.; Shin, J.H.; Shin, J.Y.; Shin, Y.G.; Chung, C.H. Alcohol consumption, liver enzymes, and prevalence of metabolic syndrome in Korean adult men. Hypertension 2007, 16, 253–260. [Google Scholar] [CrossRef] [Green Version]
  14. Park, J.K.; Kweon, S.H.; Kim, Y.H.; Jang, M.J.; Oh, K.W. Dietary behaviors related to metabolic syndrome in Korean adults. Korean J. Community Nutr. 2012, 17, 664–675. [Google Scholar] [CrossRef]
  15. Bae, Y.J. Relationship among practicing healthy diet and metabolic syndrome indicators in adults-from the Korea National Health and Nutrition Examination Survey, 2013~2014. J. Nutr. Health 2016, 49, 459–470. [Google Scholar] [CrossRef] [Green Version]
  16. Miedico, O.; Pompa, C.; Tancredi, C.; Cera, A.; Pellegrino, E.; Tarallo, M.; Chiaravalle, A.E. Characterisation and chemometric evaluation of 21 trace elements in three edible seaweed species imported from south-east Asia. J. Food Compos. Anal. 2017, 64, 188–197. [Google Scholar] [CrossRef]
  17. Kumar, S.A.; Brown, L. Seaweeds as potential therapeutic interventions for the metabolic syndrome. Rev. Endocr. Metab. Disord. 2013, 14, 299–308. [Google Scholar] [CrossRef]
  18. Korean Statistical Information Service (KOSIS). Daily Intake Trend by Food Group (Standardized). Available online: https://kosis.kr/statHtml/statHtml.do?orgId=177&tblId=DT_11702_N221&vw_cd=MT_OTITLE&list_id=117_11702_A01_033_001&scrId=&seqNo=&lang_mode=ko&obj_var_id=&itm_id=&conn_path=K2&path=%252Fcommon%252Fmeta_onedepth.jsp (accessed on 25 January 2022).
  19. Choi, M.K. Analysis of seaweed consumption in Korean adults using the 2016 Korea National Health and Nutrition Examination Survey. Korean J. Food Sci. Technol. 2019, 48, 597–604. [Google Scholar] [CrossRef]
  20. Korea Health Industry Development Institute (KHIDI). Consumption by Food Group. Available online: https://www.khidi.or.kr/kps/dhraStat/result1?menuId=MENU01652&year=2019 (accessed on 25 January 2022).
  21. Lordan, S.; Ross, R.P.; Stanton, C. Marine bioactives as functional food ingredients: Potential to reduce the incidence of chronic diseases. Mar. Drugs 2011, 9, 1056. [Google Scholar] [CrossRef] [Green Version]
  22. Rajapakse, N.; Kim, S.K. Nutritional and digestive health benefits of seaweed. Adv. Food Nutr. Res. 2011, 64, 17–28. [Google Scholar] [CrossRef]
  23. Parnell, J.A.; Reimer, R.A. Prebiotic fiber modulation of the gut microbiota improves risk factors for obesity and the metabolic syndrome. Gut Microbes 2012, 3, 29–34. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Martin, F.-P.J.; Wang, Y.; Sprenger, N.; Yap, I.K.S.; Lundstedt, T.; Lek, P.; Rezzi, S.; Ramadan, Z.; Bladeren, P.v.; Fay, L.B.; et al. Probiotic modulation of symbiotic gut microbial–host metabolic interactions in a humanized microbiome mouse model. Mol. Syst. Biol. 2008, 4, 157. [Google Scholar] [CrossRef] [Green Version]
  25. Park, J.K.; Woo, H.W.; Kim, M.K.; Shin, J.H.; Lee, Y.H.; Shin, D.H.; Shin, M.H.; Choi, B.Y. Dietary iodine, seaweed consumption, and incidence risk of metabolic syndrome among postmenopausal women: A prospective analysis of the Korean Multi-Rural Communities Cohort Study (MRCohort). Eur. J. Nutr. 2021, 60, 135–146. [Google Scholar] [CrossRef] [PubMed]
  26. Choi, S.Y.; Lee, S.Y.; Jang, D.h.; Lee, S.J.; Cho, J.Y.; Kim, S.H. Inhibitory effects of Porphyra dentata extract on 3T3-L1 adipocyte differentiation. J. Anim. Sci. Technol. 2020, 62, 854. [Google Scholar] [CrossRef] [PubMed]
  27. Lee, J.M.; You, S.G.; Kim, S.M. Functional activities of low molecular weight peptides purified from enzymatic hydrolysates of seaweeds. J. Korean Soc. Food Sci. Nutr. 2005, 34, 1124–1129. [Google Scholar] [CrossRef]
  28. Kim, S.K.; Byun, H.G. Production and biological applications for marine proteins and peptides—An overview. Food Sci. Ind. 2018, 51, 278–301. [Google Scholar] [CrossRef]
  29. Kim, M.J.; Jeon, J.; Lee, J.S. Fucoidan prevents high-fat diet-induced obesity in animals by suppression of fat accumulation. Phytother. Res. 2014, 28, 137–143. [Google Scholar] [CrossRef]
  30. Wong, K.H.; Sam, S.W.; Cheung, P.C.K.; AngJr, P.O. Changes in lipid profiles of rats fed with seaweed-based diets. Nutr. Res. 1999, 19, 1519–1527. [Google Scholar] [CrossRef]
  31. Kim, Y.J.; Han, B.G.; KoGES Group. Cohort profile: The Korean genome and epidemiology study (KoGES) consortium. Int. J. Epidemiol. 2017, 46, e20. [Google Scholar] [CrossRef]
  32. Ritchie, S.A.; Connell, J.M.C. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr. Metab. Cardiovasc. Dis. 2007, 17, 319–326. [Google Scholar] [CrossRef]
  33. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285, 2486–2497. [Google Scholar] [CrossRef] [PubMed]
  34. Kim, S.Y.; Nah, E.H.; Cho, S. Prevalence of Comorbidities among Patients with Diabetes. J. Health Inf. Stat. 2018, 43, 237–244. [Google Scholar] [CrossRef] [Green Version]
  35. Kim, C.O.; Kim, Y.N.; Lee, D.C. Effects of Gelidium elegans on weight and fat mass reduction and obesity biomarkers in overweight or obese adults: A randomized double-blinded study. Nutrients 2019, 11, 1513. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Teas, J.; Baldeon, M.E.; Chiriboga, D.E.; Davis, J.R.; Sarries, A.J.; Braverman, L.E. Could dietary seaweed reverse the metabolic syndrome? Asia Pac. J. Clin. Nutr. 2009, 18, 145–154. [Google Scholar] [PubMed]
  37. Shin, A.S.; Lim, S.Y.; Sung, J.H.; Shin, H.R.; Kim, J.S. Dietary intake, eating habits, and metabolic syndrome in Korean men. J. Acad. Nutr. Diet 2009, 109, 633–640. [Google Scholar] [CrossRef] [PubMed]
  38. Nishiumi, S.; Izumi, Y.; Kobayashi, T.; Yoshida, M. A pilot study: Effects of kombu intake on lifestyle-related diseases-possibility that kombu intake is effective in individuals with abnormally high serum triglyceride levels. Food Sci. Technol. Res. 2019, 25, 827–834. [Google Scholar] [CrossRef]
  39. Kwon, M.J.; Nam, T.J. Effects of mesangi (Capsosiphon fulvecens) powder on lipid metabolism in high cholesterol fed rats. J. Korean Soc. Food Sci. Nutr. 2006, 35, 530–535. [Google Scholar] [CrossRef]
  40. Lailatussifa, R.; Husni, A.; Nugroho, A.E. Anti-stress activity of Sargassum polycystum extracts using a cold restraint stress model. Food Sci. Biotechnol. 2016, 25, 589–594. [Google Scholar] [CrossRef]
  41. Zeng, A.; Yang, R.; Yu, S.; Zhao, W. A novel hypoglycemic agent: Polysaccharides from laver (Porphyra spp.). Food Funct. 2020, 11, 9048–9056. [Google Scholar] [CrossRef]
  42. Cho, M.J.; Lee, E.K.; Kim, S.S. Relationship between seaweed intake and the risk of diabetes: Korean Genome and Epidemiology Study, KoGES (Ansan and Ansung Study). Public Health Wkly. Rep. 2017, 10, 2–9. [Google Scholar]
  43. Ren, D.; Noda, H.; Amano, H.; Nishino, T.; Nishizawa, K. Study on antihypertensive and antihyperlipidemic effects of marine algae. Fish Sci. 1994, 60, 83–88. [Google Scholar] [CrossRef] [Green Version]
  44. Wada, K.; Tsuji, M.; Nakamura, K.; Oba, S.; Nishizawa, S.; Yamamoto, K.; Watanabe, K.; Ando, K.; Nagata, C. Effect of dietary nori (dried laver) on blood pressure in young Japanese children: An intervention study. J. Epidemiol. 2021, 31, 37–42. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. Koo, H.S.; Roh, J.S.; Yoon, Y.R.; Kim, H.J.; Kwon, M.J.; Choi, H.S.; Song, Y.O. The effect of kelp cabbage kimchi on weight loss and lipid loss. Korean J. Food Sci. Technol. 2007, 36, 1140–1147. [Google Scholar]
  46. Matanjun, P.; Mohamed, S.; Mustapha, N.M.; Muhammad, K. Nutrient content of tropical edible seaweeds, Eucheuma cottonii, Caulerpa lentillifera and Sargassum polycystum. J. Appl. Phycol. 2009, 21, 75–80. [Google Scholar] [CrossRef]
  47. Jung, B.M.; Jung, K.J. Effect of porphyran drink on serum and liver cholesterol contents in hypercholesterolemic rat. J. Korean Soc. Food Sci. Nutr. 2005, 34, 1357–1361. [Google Scholar] [CrossRef]
  48. Kim, E.; Kim, M.S.; Kim, S.Y.; Kim, H.A. Effect of Ecklonia cava on the blood glucose, lipids and renal oxidative stress in diabetic rats. J. Korean Soc. Food Cult. 2008, 23, 812–819. [Google Scholar]
  49. Shin, J.H.; Choi, D.J.; Lim, H.C.; Seo, J.K.; Lee, S.J.; Choi, S.Y.; Sung, N.J. Nutrients and antioxidant activity of red seaweeds. J. Life Sci. 2006, 16, 400–408. [Google Scholar] [CrossRef]
Foods 11 01635 g001 550
Figure 1. Process flowchart outlining the steps of this analysis.
Figure 1. Process flowchart outlining the steps of this analysis.
Foods 11 01635 g001
Table
Table 1. General characteristics according to tertiles of total seaweed consumption in the Korean Genome and Epidemiology Study (Ansan and Ansung).
Table 1. General characteristics according to tertiles of total seaweed consumption in the Korean Genome and Epidemiology Study (Ansan and Ansung).
VariablesTertile of Total Seaweed Consumptionp-Value
T1 (Lowest) (n = 1945)T2 (n = 1628)T3 (Highest) (n = 2204)
Age (years)51.3 ± 8.7 (1)49.9 ± 8.349.4 ± 8.1<0.0001
Education <0.0001
Elementary/middle school1124 (57.8%)750 (46.1%)965 (43.8%)
High school/technical college657 (33.8%)690 (42.4%)939 (42.6%)
University164 (8.4%)188 (11.5%)300 (13.6%)
Income (million KRW/month) <0.0001
< 1706 (36.3%)392 (24.1%)483 (21.9%)
1–3933 (48.0%)845 (51.9%)1143 (51.9%)
> 3306 (15.7%)391 (24.0%)578 (26.2%)
Smoking status 0.02
None1075 (55.3%)962 (59.1%)1323 (60.0%)
Past307 (15.8%)247 (15.2%)333 (15.1%)
Current563 (28.9%)419 (25.7%)548 (24.9%)
Alcohol consumption 0.015
None810 (41.6%)718 (44.1%)1027 (46.6%)
Past 126 (6.5%)90 (5.5%)110 (5.0%)
Current 1009 (51.9%)820 (50.4%)1067 (48.4%)
Region <0.0001
Ansung (rural)852 (43.8%)441 (27.1%)558 (25.3%)
Ansan (urban)1093 (56.2%)1187 (72.9%)1646 (74.7%)
Physical activity (MET-h/d)23.6 ± 14.921.3 ± 13.121.7 ± 13.1<0.0001
Body mass index (kg/m2)24.1 ± 3.024.3 ± 3.024.6 ± 3.0<0.0001
MET: metabolic equivalent of task. (1) Values are presented as the mean ± standard deviation.
Table
Table 2. Dietary intake and clinical characteristics according to tertiles of total seaweed consumption in the Korean Genome and Epidemiology Study (Ansan and Ansung).
Table 2. Dietary intake and clinical characteristics according to tertiles of total seaweed consumption in the Korean Genome and Epidemiology Study (Ansan and Ansung).
VariablesTertile of Total Seaweed Consumptionp-Value
Tertile 1 (Lowest)Tertile 2Tertile 3 (Highest)
Dietary intake
Total energy (kcal)1748.6 ± 575.3 (1)1912 ± 525.12182.9 ± 758.3<0.0001
Protein (g)55.5 ± 22.365.2 ± 21.280.3 ± 35.1<0.0001
Fat (g)26.8 ± 16.932.7 ± 16.041.2 ± 24.9<0.0001
Carbohydrates (g)315.5 ± 98.6334.3 ± 92.0368.9 ± 121.8<0.0001
Dietary fiber (g)5.9 ± 2.86.7 ± 2.78.1 ± 3.8<0.0001
Total seaweed (g)0.5 ± 0.31.4 ± 0.33.6 ± 2.2<0.0001
Laver (g)0.3 ± 0.20.8 ± 0.42.0 ± 1.4<0.0001
Kelp/sea mustard (g)0.2 ± 0.20.7 ± 0.41.6 ± 1.7<0.0001
Components of metabolic syndrome
Waist circumference (cm)81.4 ± 8.581.0 ± 8.581.2 ± 8.60.157
Fasting glucose (mg/dL)86.4 ± 21.886.6 ± 19.387.7 ± 22.90.095
Triglycerides (mg/dL)157.7 ± 104.2156.8 ± 98.1151.6 ± 101.10.117
HDL cholesterol (mg/dL)45.1 ± 10.045.0 ± 9.945.3 ± 10.10.634
Systolic blood pressure (mmHg)118.4 ± 16.4116.2 ± 16.0116.7 ± 16.4<0.0001
Diastolic blood pressure (mmHg)78.8 ± 10.777.4 ± 10.878.0 ± 11.0<0.0001
HDL cholesterol: high-density lipoprotein cholesterol. (1) Values are presented as the mean ± standard deviation.
Table
Table 3. Odds ratios (ORs) and 95% confidence intervals (CIs) of metabolic syndrome according to tertiles of total seaweed, laver, and kelp/sea mustard consumption in the Korean Genome and Epidemiology Study (Ansan and Ansung).
Table 3. Odds ratios (ORs) and 95% confidence intervals (CIs) of metabolic syndrome according to tertiles of total seaweed, laver, and kelp/sea mustard consumption in the Korean Genome and Epidemiology Study (Ansan and Ansung).
MenWomen
Tertile of Seaweed Consumptionp-Value for Trend (2)Tertile of Seaweed Consumptionp-Value for Trend
T1 (Lowest)T2T3 (Highest)T1 (Lowest)T2T3 (Highest)
OR (95% CI) (1)OR (95% CI)OR (95% CI) OR (95% CI)OR (95% CI)OR (95% CI)
Total seaweed
Cases/Total (n)218/1012192/861224/963 326/988264/958275/995
Crude model1.001.05 (0.84–1.31)1.10 (0.89–1.36)0.361.000.77 (0.64–0.94)0.78 (0.64–0.94)0.025
Adjusted model (1)1.000.98 (0.76–1.26)0.84 (0.64–1.10)0.1881.000.90 (0.71–1.13)0.85 (0.67–1.09)0.244
Laver
Cases/Total (n)142/625299/1342193/869 246/690371/1323248/928
Crude model1.000.98 (0.78–1.22)0.97 (0.76–1.24)0.8601.000.70 (0.58–0.86)0.66 (0.53–0.82)0.003
Adjusted model1.001.09 (0.83–1.42)0.78 (0.57–1.06)0.0161.000.84 (0.66–1.06)0.70 (0.54–0.92)0.014
Kelp/sea mustard
Cases/Total (n)231/1095150/673253/1068 261/813221/741383/1387
Crude model1.001.07 (0.85–1.35)1.16 (0.95–1.42)0.1501.000.90 (0.73–1.12)0.81 (0.67–0.97)0.028
Adjusted model1.001.08 (0.83–1.41)1.11 (0.87–1.41)0.4601.000.99 (0.77–1.27)0.92 (0.73–1.16)0.446
(1) Adjusted for age, region, alcohol consumption, smoking status, education level, income level, BMI, physical activity level, total energy intake, and protein, fat, carbohydrate, and fiber intake; (2) p for trend was calculated by using the median value of the seaweed intake in each category.
Table
Table 4. Odds ratios (ORs) and 95% confidence intervals (CIs) of individual metabolic syndrome components according to tertiles of total seaweed, laver, and kelp/sea mustard consumption in the Korean Genome and Epidemiology Study (Ansan and Ansung).
Table 4. Odds ratios (ORs) and 95% confidence intervals (CIs) of individual metabolic syndrome components according to tertiles of total seaweed, laver, and kelp/sea mustard consumption in the Korean Genome and Epidemiology Study (Ansan and Ansung).
MenWomen
Tertile of Seaweed Consumptionp-Value
for
Trend (2)		Tertile of Seaweed Consumptionp-Value for Trend
T1 (Lowest)T2T3 (Highest)T1 (Lowest)T2T3 (Highest)
OR (95% CI) (1)OR (95% CI)OR (95% CI) OR (95% CI)OR (95% CI)OR (95% CI)
Total seaweed
Abdominal obesity1.000.99 (0.69–1.41)0.83 (0.58–1.21)0.3011.000.85 (0.66–1.11)0.91 (0.68–1.20)0.641
Elevated triglycerides1.001.10 (0.90–1.34)0.89 (0.72–1.10)0.2071.000.93 (0.75–1.24)0.90 (0.72–1.13)0.421
Elevated fasting glucose1.000.82 (0.51–1.31)0.94 (0.59–1.49)0.9151.000.86 (0.47–1.57)0.86 (0.46–1.61)0.709
Elevated blood pressure1.000.85 (0.70–1.03)0.98 (0.80–1.21)0.9671.000.86 (0.70–1.05)0.93 (0.75–1.15)0.696
Low HDL cholesterol1.000.92 (0.75–1.13)0.83 (0.67–1.03)0.0961.000.96 (0.78–1.17)0.94 (0.76–1.17)0.610
Laver
Abdominal obesity1.000.79 (0.54–1.15)0.64 (0.42–0.98)0.0581.000.62 (0.47–0.81)0.53 (0.39–0.72)0.001
Elevated triglycerides1.001.09 (0.88–1.35)0.88 (0.69–1.12)0.0651.000.93 (0.75–1.15)0.81 (0.64–1.04)0.089
Elevated fasting glucose1.000.73 (0.45–1.19)0.79 (0.47–1.34)0.7481.000.99 (0.51–1.94)1.26 (0.63–2.52)0.385
Elevated blood pressure1.000.91 (0.74–1.12)0.97(0.76–1.22)0.8841.001.04 (0.84–1.28)1.09 (0.86–1.38)0.496
Low HDL cholesterol1.001.10 (0.88–1.37)0.81 (0.63–1.04)0.0081.000.89 (0.72–1.10)0.92 (0.73–1.17)0.780
Kelp/sea mustard
Abdominal obesity1.001.27 (0.87–1.81)1.08 (0.77–1.52)0.8641.000.76 (0.56–1.00)1.05 (0.81–1.37)0.236
Elevated triglycerides1.000.91 (0.74–1.12)0.96 (0.79–1.16)0.8171.001.05 (0.83–1.32)0.94 (0.76–1.16)0.383
Elevated fasting glucose1.001.17 (0.73–1.89)1.14 (0.74–1.75)0.6601.001.70 (0.90–3.21)0.79 (0.41–1.51)0.103
Elevated blood pressure1.000.80 (0.65–0.97)0.89 (0.74–1.08)0.4371.001.01 (0.81–1.27)0.88 (0.72–1.08)0.155
Low HDL cholesterol1.001.11 (0.90–1.37)1.04 (0.86–1.27)0.8241.001.04 (0.83–1.29)1.01 (0.83–1.23)0.992
HDL cholesterol: high-density lipoprotein cholesterol. (1) Adjusted for age, region, alcohol consumption, smoking status, education level, income level, physical activity level, total energy intake, and protein, fat, carbohydrate, and fiber intake; (2) p for trend was calculated using the median value of seaweed intake in each category.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Park, H.; Lee, K.W.; Shin, D. Association of Seaweed Consumption with Metabolic Syndrome and Its Components: Findings from the Korean Genome and Epidemiology Study. Foods 2022, 11, 1635. https://doi.org/10.3390/foods11111635

AMA Style

Park H, Lee KW, Shin D. Association of Seaweed Consumption with Metabolic Syndrome and Its Components: Findings from the Korean Genome and Epidemiology Study. Foods. 2022; 11(11):1635. https://doi.org/10.3390/foods11111635

Chicago/Turabian Style

Park, Haeun, Kyung Won Lee, and Dayeon Shin. 2022. "Association of Seaweed Consumption with Metabolic Syndrome and Its Components: Findings from the Korean Genome and Epidemiology Study" Foods 11, no. 11: 1635. https://doi.org/10.3390/foods11111635

APA Style

Park, H., Lee, K. W., & Shin, D. (2022). Association of Seaweed Consumption with Metabolic Syndrome and Its Components: Findings from the Korean Genome and Epidemiology Study. Foods, 11(11), 1635. https://doi.org/10.3390/foods11111635

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop